- Home
- SAGE vs SNDA Comparison
SAGE vs SNDA Comparison
Compare SAGE & SNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- SNDA
- Stock Information
- Founded
- SAGE 2010
- SNDA 1990
- Country
- SAGE United States
- SNDA United States
- Employees
- SAGE N/A
- SNDA N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- SNDA Hospital/Nursing Management
- Sector
- SAGE Health Care
- SNDA Health Care
- Exchange
- SAGE Nasdaq
- SNDA Nasdaq
- Market Cap
- SAGE 462.2M
- SNDA 462.3M
- IPO Year
- SAGE 2014
- SNDA 1997
- Fundamental
- Price
- SAGE $6.94
- SNDA $23.31
- Analyst Decision
- SAGE Hold
- SNDA Hold
- Analyst Count
- SAGE 20
- SNDA 1
- Target Price
- SAGE $11.39
- SNDA $25.00
- AVG Volume (30 Days)
- SAGE 2.8M
- SNDA 68.5K
- Earning Date
- SAGE 02-12-2025
- SNDA 11-13-2024
- Dividend Yield
- SAGE N/A
- SNDA N/A
- EPS Growth
- SAGE N/A
- SNDA N/A
- EPS
- SAGE N/A
- SNDA N/A
- Revenue
- SAGE $106,399,000.00
- SNDA $253,196,000.00
- Revenue This Year
- SAGE N/A
- SNDA $14.30
- Revenue Next Year
- SAGE $122.32
- SNDA $9.72
- P/E Ratio
- SAGE N/A
- SNDA N/A
- Revenue Growth
- SAGE 837.60
- SNDA 10.95
- 52 Week Low
- SAGE $4.62
- SNDA $8.84
- 52 Week High
- SAGE $27.68
- SNDA $34.26
- Technical
- Relative Strength Index (RSI)
- SAGE 60.28
- SNDA 52.24
- Support Level
- SAGE $6.75
- SNDA $22.10
- Resistance Level
- SAGE $7.88
- SNDA $23.45
- Average True Range (ATR)
- SAGE 0.38
- SNDA 0.80
- MACD
- SAGE 0.13
- SNDA 0.15
- Stochastic Oscillator
- SAGE 64.39
- SNDA 91.67
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About SNDA Sonida Senior Living Inc.
Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.